Seres Therapeutics, Inc. (MCRB) financial statements and ratios from SEC XBRL: revenue $789000.00 (TTM), net margin 721.9%, revenue growth -80.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $789000.00 |
| Net Margin | 721.9% |
| Revenue Growth (YoY) | -80.1% |
| FCF Growth (YoY) | -100.6% |
| Price / Book | 1.32 |
| Price / Sales | 25.20 |
| FCF Yield | -123.0% |
| Altman Z-Score | -11.55 (distress) |
| Sector P/E (Healthcare) | 21.7 |
MCRB overview · MCRB earnings · MCRB KPIs · MCRB investor relations · MCRB ownership · MCRB peers · MCRB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.